TEVA

Teva Pharmaceutical Industries

Healthcare Drug Manufacturers - Specialty & Generic NYSE

About the company

Teva Pharmaceutical Industries Ltd., headquartered in Petah Tikva, Israel, has established itself as the global leader in generic drug manufacturing. With a remarkable track record and a presence in over 60 countries, Teva is renowned for its commitment to providing affordable and accessible healthcare solutions to millions of people worldwide. In North America, Teva enjoys a prominent position, generating approximately half of its sales from this region. Its significant market share in the United States has enabled the company to capture a high-single-digit percentage of the total number of generic prescriptions written in the country. This achievement is a testament to Teva's dedication to delivering high-quality, cost-effective generic medicines to patients in need. However, Teva's influence extends far beyond North America. The company has a substantial presence in Europe, where it has earned the trust of healthcare providers and patients alike. Its commitment to quality and innovation has allowed Teva to establish a strong foothold in countries such as Germany, France, and the United Kingdom. In addition to Europe, Teva has also found success in other key markets, including Japan, Russia, and its home country, Israel. While generic drugs form the core of Teva's portfolio, the company has also invested in developing innovative medicines and biosimilars. Teva's dedication to improving patients' lives can be seen through its therapeutic areas of focus, namely central nervous system disorders, respiratory diseases, and oncology. In the field of central nervous system disorders, Teva offers several groundbreaking medications. Copaxone, for example, is a highly effective treatment for multiple sclerosis that has revolutionized the lives of patients worldwide. In addition, Teva's innovative therapies such as Ajovy and Austedo provide much-needed relief for patients suffering from migraine headaches and Huntington's disease, respectively. The respiratory therapeutic area is another key focus for Teva. With medications like Qvar and ProAir, the company aims to address the needs of patients with conditions such as asthma and chronic obstructive pulmonary disease (COPD). These medications have helped countless individuals manage their respiratory conditions and improve their quality of life. In the field of oncology, Teva has developed a range of innovative therapies to combat cancer. Truxima, Herzuma, and Bendeka/Treanda are just a few examples of Teva's commitment to developing effective treatments for patients fighting various types of cancer. These medications have demonstrated significant clinical benefits and have brought hope to numerous individuals and their families. Moreover, Teva's contributions extend beyond manufacturing medications. The company is also involved in the production of active pharmaceutical ingredients (APIs), which are key components used in drug manufacturing processes. With its expertise in API production, Teva plays a crucial role in ensuring the availability and quality of essential medications worldwide. Additionally, the company offers contract manufacturing services, providing pharmaceutical companies with the opportunity to leverage Teva's manufacturing capabilities, expertise, and infrastructure. This enables partners to expedite their drug development process and bring essential medications to market more efficiently. To complement its extensive capabilities, Teva also owns Anda, a reputable U.S.-based generic and specialty drug distributor. Through Anda, Teva ensures that healthcare providers and patients across the United States have access to a wide range of generic and specialty medications, further expanding its reach and impact on the healthcare industry. As the leading generic drug manufacturer globally, Teva Pharmaceutical Industries Ltd. has demonstrated a steadfast commitment to improving global health outcomes. Through its encompassing portfolio of generics, innovative medicines, biosimilars, active pharmaceutical ingredients, contract manufacturing services, and drug distribution, Teva continues to make a meaningful difference in the lives of patients around the world.

Website: https://www.tevapharm.com

Data updated: June 2, 2026

Sector comparison

We compare this company with the typical (middle) company in the same industry to show how it looks against similar businesses. This is information, not a recommendation.

Healthcare · 1346 peers in sector

Metric TEVA Sector median Vs. industry
P/E 25.85 20.10 ↑ Above average
EPS 1.34 USD -1.14 USD ↑ Above average
Dividend yield 0.00% 0.00%
Profit margin 9.02% 0.00% ↑ Above average
ROE 21.60% -58.84% ↑ Above average

Higher and lower here are only a comparison with the typical company in the industry — a higher or lower value on its own does not mean better or worse.

Financial statements & historical data

Income statements, balance sheets, cash flow, earnings and dividend history are available for registered users

Sign up for free

AI Summary

AI-generated company analysis is available for registered users.

Sign up for free

Where does this data come from?

Frequently Asked Questions

What is Teva Pharmaceutical Industries?
Teva Pharmaceutical Industries Ltd., headquartered in Petah Tikva, Israel, has established itself as the global leader in generic drug manufacturing. With a remarkable track record and a presence in over 60 countries, Teva is renowned for its commitment to providing affordable and accessible healthcare solutions to millions of people worldwide. In North America, Teva enjoys a prominent position, generating approximately half of its sales from this region. Its significant market share in the United States has enabled the company to capture a high-single-digit percentage of the total number of generic prescriptions written in the country. This achievement is a testament to Teva's dedication to delivering high-quality, cost-effective generic medicines to patients in need. However, Teva's influence extends far beyond North America. The company has a substantial presence in Europe, where it has earned the trust of healthcare providers and patients alike. Its commitment to quality and innovation has allowed Teva to establish a strong foothold in countries such as Germany, France, and the United Kingdom. In addition to Europe, Teva has also found success in other key markets, including Japan, Russia, and its home country, Israel. While generic drugs form the core of Teva's portfolio, the company has also invested in developing innovative medicines and biosimilars. Teva's dedication to improving patients' lives can be seen through its therapeutic areas of focus, namely central nervous system disorders, respiratory diseases, and oncology. In the field of central nervous system disorders, Teva offers several groundbreaking medications. Copaxone, for example, is a highly effective treatment for multiple sclerosis that has revolutionized the lives of patients worldwide. In addition, Teva's innovative therapies such as Ajovy and Austedo provide much-needed relief for patients suffering from migraine headaches and Huntington's disease, respectively. The respiratory therapeutic area is another key focus for Teva. With medications like Qvar and ProAir, the company aims to address the needs of patients with conditions such as asthma and chronic obstructive pulmonary disease (COPD). These medications have helped countless individuals manage their respiratory conditions and improve their quality of life. In the field of oncology, Teva has developed a range of innovative therapies to combat cancer. Truxima, Herzuma, and Bendeka/Treanda are just a few examples of Teva's commitment to developing effective treatments for patients fighting various types of cancer. These medications have demonstrated significant clinical benefits and have brought hope to numerous individuals and their families. Moreover, Teva's contributions extend beyond manufacturing medications. The company is also involved in the production of active pharmaceutical ingredients (APIs), which are key components used in drug manufacturing processes. With its expertise in API production, Teva plays a crucial role in ensuring the availability and quality of essential medications worldwide. Additionally, the company offers contract manufacturing services, providing pharmaceutical companies with the opportunity to leverage Teva's manufacturing capabilities, expertise, and infrastructure. This enables partners to expedite their drug development process and bring essential medications to market more efficiently. To complement its extensive capabilities, Teva also owns Anda, a reputable U.S.-based generic and specialty drug distributor. Through Anda, Teva ensures that healthcare providers and patients across the United States have access to a wide range of generic and specialty medications, further expanding its reach and impact on the healthcare industry. As the leading generic drug manufacturer globally, Teva Pharmaceutical Industries Ltd. has demonstrated a steadfast commitment to improving global health outcomes. Through its encompassing portfolio of generics, innovative medicines, biosimilars, active pharmaceutical ingredients, contract manufacturing services, and drug distribution, Teva continues to make a meaningful difference in the lives of patients around the world.
Are Teva Pharmaceutical Industries shares expensive?
The price-to-earnings (P/E) ratio of Teva Pharmaceutical Industries is 25.85 — the share price is 25.85 times the annual profit per share. That is higher than the typical company in the same industry (industry median: 20.10). This is information, not a recommendation. (as of 2026-06-02)
How big is Teva Pharmaceutical Industries?
The market capitalization of Teva Pharmaceutical Industries — the combined value of all its shares — is 40.34 B USD. The higher the market cap, the larger the company. (as of 2026-06-02)
Does Teva Pharmaceutical Industries pay dividends?
The dividend yield of Teva Pharmaceutical Industries is 0.00% — it shows the annual dividend relative to the share price. This is information, not a recommendation. (as of 2026-06-02)
What sector does Teva Pharmaceutical Industries belong to?
Teva Pharmaceutical Industries operates in the Healthcare sector, industry: Drug Manufacturers - Specialty & Generic.

What do you gain?

With Ecrumen you gain full control over your investments and assets!

All your assets
Stock market investments, real estate, bonds. Be aware of what you have in your portfolio!
AI at the service of your investments
Analyze and optimize your investments using the latest technologies. Sentiments, analyses, tips, reports. Always with up-to-date data!
A community eager to help
Find a place with people similar to you. Share your opinions, see how others manage their investments. Get help with the problems that bother you!
What do you gain?

Want to stay up to date?

Subscribe to our newsletter to stay up to date with Ecrumena news and market information. No spam, unsubscribe in one click.

For more information, please refer to our terms of use.

0/120